Cargando…

Sebelipase alfa enzyme replacement therapy in Wolman disease: a nationwide cohort with up to ten years of follow-up

BACKGROUND: Wolman disease (WD), the rapidly progressive phenotype of lysosomal acid lipase (LAL) deficiency, presents in neonates with failure to thrive and hepatosplenomegaly, and leads to multi-organ failure and death before 12 months of age. In clinical trials, enzyme replacement therapy (ERT) w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demaret, Tanguy, Lacaille, Florence, Wicker, Camille, Arnoux, Jean-Baptiste, Bouchereau, Juliette, Belloche, Claire, Gitiaux, Cyril, Grevent, David, Broissand, Christine, Adjaoud, Dalila, Abi Warde, Marie-Thérèse, Plantaz, Dominique, Bekri, Soumeya, de Lonlay, Pascale, Brassier, Anaïs
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670257/ https://www.ncbi.nlm.nih.gov/pubmed/34906190 http://dx.doi.org/10.1186/s13023-021-02134-3

Ejemplares similares

Case series of sebelipase alfa hypersensitivity reactions and successful sebelipase alfa rapid desensitization
por: Huffaker, Michelle F., et al.
Publicado: (2019)

Correction to: Case series of sebelipase alfa hypersensitivity reactions and successful sebelipase alfa rapid desensitization.
Publicado: (2020)

Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study
por: Jones, Simon A., et al.
Publicado: (2017)

Novel treatment options for lysosomal acid lipase deficiency: critical appraisal of sebelipase alfa
por: Su, Kim, et al.
Publicado: (2016)

Sebelipase alfa for lysosomal acid lipase deficiency: 5‐year treatment experience from a phase 2 open‐label extension study
por: Malinová, Vĕra, et al.
Publicado: (2020)

Initial presentation, management and follow-up data of 33 treated patients with hereditary tyrosinemia type 1 in the absence of newborn screening
por: Hajji, Hela, et al.
Publicado: (2022)

Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies
por: Vijay, Suresh, et al.
Publicado: (2021)

Correction to: Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies
por: Vijay, Suresh, et al.
Publicado: (2021)

Diagnosis, treatment, and follow-up of a case of Wolman disease with hemophagocytic lymphohistiocytosis
por: Baronio, Federico, et al.
Publicado: (2021)

Infectious and digestive complications in glycogen storage disease type Ib: Study of a French cohort
por: Wicker, Camille, et al.
Publicado: (2020)

Secondary Hemophagocytic Lymphohistiocytosis in an Infant with Wolman Disease
por: Küçükçongar Yavaş, Aynur, et al.
Publicado: (2017)

Intravenous administration of a branched-chain amino-acid-free solution in children and adults with acute decompensation of maple syrup urine disease: a prospective multicentre observational study
por: Alili, Jean-Meidi, et al.
Publicado: (2022)

Clinical outcome of a patient with lysosomal acid lipase deficiency and first results after initiation of treatment with Sebelipase alfa: A case report
por: Soll, Dominik, et al.
Publicado: (2019)

Administration of gamma‐hydroxybutyrate instead of beta‐hydroxybutyrate to a liver transplant recipient suffering from propionic acidemia and cardiomyopathy: A case report on a medication prescribing error
por: Tuchmann‐Durand, Caroline, et al.
Publicado: (2020)

Novel association of metastatic Crohn's disease and Wolman disease
por: AlAsmari, Amal, et al.
Publicado: (2021)

Enteral tube feeding in patients receiving dietary treatment for metabolic diseases: A retrospective analysis in a large French cohort
por: Bérat, Claire-Marine, et al.
Publicado: (2021)

Citrulline in the management of patients with urea cycle disorders
por: Imbard, Apolline, et al.
Publicado: (2023)

Neural stem cells for disease modeling of Wolman disease and evaluation of therapeutics
por: Aguisanda, Francis, et al.
Publicado: (2017)

Targeting Wolman Disease and Cholesteryl Ester Storage Disease: Disease Pathogenesis and Therapeutic Development
por: Aguisanda, Francis, et al.
Publicado: (2017)

CT features of Wolman disease (lysosomal acid lipase enzyme deficiency) – A case report
por: Foladi, Naqibullah, et al.
Publicado: (2021)

First LIPA Mutational Analysis in Egyptian Patients Reveals One Novel Variant: Wolman Disease
por: Elaraby, Nesma M., et al.
Publicado: (2023)

Recombinant FVIII Products (Turoctocog Alfa and Turoctocog Alfa Pegol) Stable Up to 40°C
por: Napolitano, Mariasanta, et al.
Publicado: (2021)

Enzyme replacement therapy and hematopoietic stem cell transplant: a new paradigm of treatment in Wolman disease
por: Potter, Jane E., et al.
Publicado: (2021)

Paving the Way to Precision Nutrition Through Metabolomics
por: Tebani, Abdellah, et al.
Publicado: (2019)

GEANT4 simulation of the testbeam set-up for the ALFA detector
por: Vorobel, V, et al.
Publicado: (2006)

Wolman’s disease presenting with secondary hemophagocytic lymphohistiocytosis: a case report from Saudi Arabia and literature review
por: Alabbas, Fahad, et al.
Publicado: (2021)

Long term follow-up after haematopoietic stem cell transplantation for mucopolysaccharidosis type I-H: a retrospective study of 51 patients
por: Gardin, Antoine, et al.
Publicado: (2022)

Advances in metabolome information retrieval: turning chemistry into biology. Part II: biological information recovery
por: Tebani, Abdellah, et al.
Publicado: (2017)

Advances in metabolome information retrieval: turning chemistry into biology. Part I: analytical chemistry of the metabolome
por: Tebani, Abdellah, et al.
Publicado: (2017)

Wolman disease presenting with hemophagocytic lymphohistiocytosis syndrome and a novel LIPA gene variant: a case report and review of the literature
por: Asna Ashari, Kosar, et al.
Publicado: (2023)

Myogenic Disease and Metabolic Acidosis: Consider Multiple Acyl-Coenzyme A Dehydrogenase Deficiency
por: Dernoncourt, A., et al.
Publicado: (2019)

Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations
por: Tebani, Abdellah, et al.
Publicado: (2016)

Intraventricular Hemorrhage in Very Preterm Infants: A Comprehensive Review
por: Gilard, Vianney, et al.
Publicado: (2020)

Long-term renal outcome in methylmalonic acidemia in adolescents and adults
por: Dao, Myriam, et al.
Publicado: (2021)

Renoprotective Effect of Agalsidase Alfa: A Long-Term Follow-Up of Patients with Fabry Disease
por: Cybulla, Markus, et al.
Publicado: (2022)

Efficacy and safety of i.v. sodium benzoate in urea cycle disorders: a multicentre retrospective study
por: Husson, Marie-Caroline, et al.
Publicado: (2016)

Precision Neurosurgery: A Path Forward
por: Gilard, Vianney, et al.
Publicado: (2021)

Congenital hyperinsulinism: current trends in diagnosis and therapy
por: Arnoux, Jean-Baptiste, et al.
Publicado: (2011)

Abatacept for severe anti-TNF-alfa refractory JIA-associated uveitis: one year follow-up
por: Alpigiani, MG, et al.
Publicado: (2011)

Fibre tests for the ALFA detector with a lab set-up using a Sr-90 source
por: Joram, C, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_3sp00ahnnasd2t02diic3fqdku